Literature DB >> 30326068

Neural Plasticity Following Surgical Correction of Strabismus in Monkeys.

Mythri Pullela1, Mehmet N Agaoglu1, Anand C Joshi1, Sevda Agaoglu1, David K Coats2, Vallabh E Das1.   

Abstract

Purpose: Although widely practiced, surgical treatment of strabismus has varying levels of success and permanence. In this study we investigated adaptive responses within the brain and the extraocular muscles (EOM) that occur following surgery and therefore determine long-term success of the treatment.
Methods: Single cell responses were collected from cells in the oculomotor and abducens nuclei before and after two monkeys (M1, M2) with exotropia (divergent strabismus) underwent a strabismus correction surgery that involved weakening of the lateral rectus (LR) and strengthening of the medial rectus (MR) muscle of one eye. Eye movement and neuronal data were collected for up to 10 months after surgery during a monocular viewing smooth-pursuit task. These data were fit with a first-order equation and resulting coefficients were used to estimate the population neuronal drive (ND) to each EOM of both eyes.
Results: Surgery resulted in a ∼70% reduction in strabismus angle in both animals that reverted toward presurgical misalignment by approximately 6 months after treatment. In the first month after surgery, the ND to the treated MR reduced in one animal and ND to the LR increased in the other animal, both indicating active neural plasticity that reduced the effectiveness of the treatment. Adaptive changes in ND to the untreated eye were also identified. Conclusions: Active neural and muscle plasticity corresponding to both the treated and the untreated eye determines longitudinal success following surgical correction of strabismus. Outcome of surgical treatment could be improved by identifying ways to enhance "positive" adaptation and limit "negative" adaptation.

Entities:  

Mesh:

Year:  2018        PMID: 30326068      PMCID: PMC6188463          DOI: 10.1167/iovs.18-25245

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  48 in total

1.  Dynamics of abducens nucleus neuron discharges during disjunctive saccades.

Authors:  Pierre A Sylvestre; Kathleen E Cullen
Journal:  J Neurophysiol       Date:  2002-12       Impact factor: 2.714

2.  Increased extraocular muscle strength with direct injection of insulin-like growth factor-I.

Authors:  Brian C Anderson; Stephen P Christiansen; Steven Grandt; Robert W Grange; Linda K McLoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-06       Impact factor: 4.799

3.  The effect of resection on satellite cell activity in rabbit extraocular muscle.

Authors:  Stephen P Christiansen; Linda K McLoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-02       Impact factor: 4.799

4.  Responses of cells in the midbrain near-response area in monkeys with strabismus.

Authors:  Vallabh E Das
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-22       Impact factor: 4.799

5.  Increased frequency of activated satellite cells in overacting inferior oblique muscles from humans.

Authors:  Rosália M S Antunes-Foschini; Fernando S Ramalho; Leandra N Z Ramalho; Harley E A Bicas
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

6.  Post-operative strabismus control and motor alignment for basic intermittent exotropia.

Authors:  Fiona Lee Min Chew; Bhambi Uellyn Gesite-de Leon; Boon Long Quah
Journal:  Int J Ophthalmol       Date:  2016-07-18       Impact factor: 1.779

7.  Neural control of vergence eye movements: activity of abducens and oculomotor neurons.

Authors:  L E Mays; J D Porter
Journal:  J Neurophysiol       Date:  1984-10       Impact factor: 2.714

8.  Incidence and types of childhood esotropia: a population-based study.

Authors:  Amy E Greenberg; Brian G Mohney; Nancy N Diehl; James P Burke
Journal:  Ophthalmology       Date:  2006-10-27       Impact factor: 12.079

9.  Long-term follow-up of congenital esotropia in a population-based cohort.

Authors:  Curtis R Louwagie; Nancy N Diehl; Amy E Greenberg; Brian G Mohney
Journal:  J AAPOS       Date:  2008-11-06       Impact factor: 1.220

10.  Postoperative outcomes in children with intermittent exotropia from a population-based cohort.

Authors:  Noha S Ekdawi; Kevin J Nusz; Nancy N Diehl; Brian G Mohney
Journal:  J AAPOS       Date:  2008-10-10       Impact factor: 1.220

View more
  6 in total

1.  Can Clinical Measures of Postoperative Binocular Function Predict the Long-Term Stability of Postoperative Alignment in Intermittent Exotropia?

Authors:  Yidong Wu; Meiping Xu; Junxiao Zhang; Jinjing Zhou; Minghui Wan; Zhiyue Dai; Tingting Peng; Seung Hyun Min; Fang Hou; Jiawei Zhou; Xinping Yu
Journal:  J Ophthalmol       Date:  2020-07-21       Impact factor: 1.909

2.  Childhood Onset Strabismus: A Neurotrophic Factor Hypothesis.

Authors:  Jolene C Rudell; Jérome Fleuriet; Michael J Mustari; Linda K McLoon
Journal:  J Binocul Vis Ocul Motil       Date:  2021-04-19

3.  Eye alignment changes caused by sustained GDNF treatment of an extraocular muscle in infant non-human primates.

Authors:  Jérome Fleuriet; Christy L Willoughby; Rachel B Kueppers; Michael J Mustari; Linda K McLoon
Journal:  Sci Rep       Date:  2020-07-17       Impact factor: 4.379

4.  Fixation eye movement abnormalities and stereopsis recovery following strabismus repair.

Authors:  Talora L Martin; Jordan Murray; Kiran Garg; Charles Gallagher; Aasef G Shaikh; Fatema F Ghasia
Journal:  Sci Rep       Date:  2021-07-13       Impact factor: 4.379

5.  Morphological Differences in the Inferior Oblique Muscles from Subjects with Over-elevation in Adduction.

Authors:  Jolene C Rudell; David Stager; Joost Felius; Linda K McLoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

6.  Effect of Fibroblast Growth Factor 2 on Extraocular Muscle Structure and Function.

Authors:  Jolene C Rudell; Linda K McLoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-07-01       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.